Why we launched @BTMPublicPolicy

Public policy is just as important as medical research in saving lives.

The Health and Public Policy Team works tirelessly every day to ensure patient access to cellular therapies. From helping to resolve individual hematopoietic cell transplant (HCT) claims issues to leading national advocacy efforts to improve coverage and reimbursement, we serve patients, families, donors, hospitals and other stakeholders in an effort to save more lives.

To support this work and build an advocacy network, we are launching our own Twitter channel, @BTMPublicPolicy.

We know 100% of Members of Congress are on Twitter and Facebook and most of those Members manage their Twitter account personally. They all have profiles on these platforms because they know that their constituents do too. 
This is where we can engage to teach them about our Program and the impact we have on blood cancer and blood disease patients across the country.
 
Health and Public Policy Director, Susan Leppke, stated, “This new channel will help further the organization’s mission.” She added, “Advocacy and public policy is critically important to ensuring all patients have equal access to life-saving cellular therapy. Engaging Lawmakers on social media is a key part of this process to increase our digital footprint.” Even if you’re not on Twitter yet, take a moment to create an account and follow us. Take your advocacy to a new level and tweet!